Here are seven key notes on the offering:
1. The company hopes to raise $60 million.
2. Four million shares will be offered.
3. Price range is $14 to $16.
4. At midpoint, Invuity would command a fully diluted market value of $207 million.
5. At midpoint, Invuity would command an enterprise value of $144 million.
6. Piper Jaffray, Leerink Partners and Stifel are joint bookrunners.
7. The company is expected to price next week.
More articles on orthopedic devices:
Materialise partners with Consensus Orthopedics—4 things to know
MIS SI joint fusions: 5 key notes
NuVasive, VertiFlex, K2M & more—12 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
